The Trial Lawyer Magazine Logo

Lexapro Birth Defects Litigation Set for Trial in May
Lexapro Birth Defects Litigation Set for Trial in May; November 17, 2013

Cole County, MO: While not particularly active in the headlines of late, Lexapro birth defects is an issue that has nonetheless kept percolating in the shadows, and is poised to make a return to the public conscience with the start of the consolidated Lexapro/Celexa Products Liability Litigation trial in May of next year.

Lexapro (escitalopram) is a member of the SRRI class of antidepressants (Selective Serotonin Reuptake Inhibitors) and is prescribed for depression. The latter, together with other forms of mental illness, continues to be a force in the US, with 25 percent of Americans suffering from diagnosable mental illness, according to the New York Times (8/19/13).

To that end, mental illness such as depression is increasingly treated with medication such as Lexapro, with one in five Americans currently prescribed at least one psychotic medication, according to Dr. Richard A. Friedman, a professor of clinical psychology at Weill Cornell Medical College, writing in the New York Times.

To read the complete article, please click here:

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram